Adlette Inati

Printer-friendly version

Personal information

Medical Doctor, Head of Division

Contact information (private)

Nini Hospital, Maarad Str.
961 6 448442 & 961 6 628434
961 6 448442
Mobile phone: 
961 3 228033
Personal email address:

Contact information (work)

Rafik Hariri University Hospital
Division of Pediatric Hematology Oncology
Bir Hassan
961 6 448442
Mobile phone: 
961 3 228033
Work email address:


Fellowship in Pediatric Hematology Oncology, 1981, Children’s Hospital Medical Center and Sidney Farber Cancer Institute, Harvard Medical School, United States of America.
Residency in Pediatrics, 1979, Children’s Hospital Medical Center, Harvard Medical School, United States of America.
Fellowship in Pediatrics, 1977, Johns Hopkins University, United States of America.
Medical Degreee, 1976, American University of Beirut, Lebanon.

Areas of Expertise

Sickle Cell Disease
Pediatric Leukemias
Preventive Medicine in Pediatrics
Road safety

Work history

Founding Faculty, 2009 - present, Medical School, Lebanese American University (Byblos).

Faculty member, 2009 - present, Hematology Module, Medical School, Lebanese American University (Byblos).

Faculty member, 2009 - present, European School of Hematology.

Research associate, 2007 - present, Balamand University.

Head of the Division of Pediatric Hematology Oncology, 2006 - present, Rafik Hariri University Hospital.

Medical Director, 2006 - present, Children’s Cancer Center, Rafik Hariri University Hospital.

Director of Blood Bank, 2001 - present, Nini Hospital.

Head of the Division of Pediatric Hematology Oncology, 1996 - present, Nini Hospital.

Consultant Hematologist, 1994 - present, Chronic Care Center.

Honorary office and memberships

Member of the International Society of Thrombosis, 2009 - present.

Vice - President of the GNK Foundation, 2006 - present.

Member of the American Society of Hematology, 2005 - present.

Member of the European Hematology Association.


Publications highlights: 
  • Inati, A., Musallam, K., Wood, J.C., & Taher, A. (2010, April 8). Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease. Blood, 115(14), 2980-1.
  • Inati, A., Musallam K. M., Wood, J. C., Sheikh-Taha, M., Daou, L., & Taher, A. T. (2009, December 1). Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. European Journal of Haematology 83(6), 565 - 571.
  • Inati, A., Taher, A., Ghorra, S., Koussa, S., Taha, M., Aoun, E., & Sharara, A.I. (2005, August). Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. British Journal of Haematology 130(4), 644 - 646.
  • Inati, A., Taher, A., Bou Alawi, W., Koussa, S., Kaspar, H., Shbaklo, H., & Zalloua, P.A. (2003, February). Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. European Journal Haematology, 70(2), 79 - 83.
  • Inati, A., Sallan, S.E., Cassady, J.R., Hitchcock-Bryan, S., Clavell, L.A., Belli, J.A., & Sollee, N. (1983, February). Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate. Blood 61(2), 297 - 303.
  • Inati, A., Propper, R., & Nathan, D. (1981). Subcutaneous deferoxamine (ScDF) plus hypertransfusion (HiTx) in thalassemia major (TM): A three year follow-up. Pediatric Research 15 (4 II), 817.
Major achievements: 

Author of more than 50 publications in peer reviewed scientific journals and of more than 100 abstracts in international meetings.

Invited speaker at more than 100 international and regional meetings.

Reviewer of multiple peer reviewed medical journals.

Awards and Distinctions

Alpha Omega Alpha for contribution to medical research, and promotion of optimal health delivery in the region, 2000.

Medal from former First Lady Mona Haraoui in recognition for unwavering committment to the Chronic Care Center, 1994 & 2004.